Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients.

Jadoul, Michel;Garbar, C.;Vanholder, R.;Sennesael, J.;Van Ypersele de Strihou, Charles;et.al.
(1998) Kidney International — Vol. 54, n° 3, p. 956-959 (1998)

Files

No attached file found for this publication.

Details

Authors
  • Jadoul, MichelUCLouvain
    Author
  • Garbar, C.
    Author
  • Vanholder, R.
    Author
  • Sennesael, J.
    Author
  • Michel, CarolineUCLouvain
    Author
  • Robert, AnnieUCLouvain
    Author
  • Noël, HenriUCLouvain
    Author
  • Van Ypersele de Strihou, CharlesUCLouvain
    Author
Show more
Abstract
BACKGROUND: The prevalence of beta2-microglobulin amyloidosis (Abeta2m) in patients on continuous ambulatory peritoneal dialysis (CAPD) is unknown. METHODS: We prospectively obtained a median of 2 (range 1 to 4) joint samples from 26 CAPD patients aged 44 to 93 (median 73) years at post-mortem evaluation after 4.5 to 126 (median 27) months solely on CAPD (N = 19) or primarily on CAPD (that is, < or = 10% and < or = 1 year of renal replacement therapy time on other modalities; N = 7). The diagnosis of Abeta2m rested on Congo red staining (typical birefringence) and positive immunostaining of amyloid deposits by a monoclonal anti-beta2m antibody. RESULTS: Abeta2m was diagnosed in 8 of 26 patients (31%). Prevalence ranged from 20% (2 of 10 patients) within < or = 24 months CAPD to 30% (3 of 10 patients) after 24 to 48 months and 50% (3 of 6 patients) after 49 to 126 months (P = 0.11). The prevalence of Abeta2m was similar in patients without or with one or more peritonitis episodes. No significant difference in prevalence (P = 0.118) was found between CAPD patients (8+/26; 31%) and hemodialysis patients (13+/26; 50%) carefully matched for time on dialysis and age at the onset of dialysis. CONCLUSIONS: The prevalence of histological Abeta2m reaches 31% after a median duration of 27 months of CAPD. This prevalence is not significantly different from that observed in a group of HD patients matched for age and dialysis duration.
Affiliations

Citations

Jadoul, M., Garbar, C., Vanholder, R., Sennesael, J., Michel, C., Robert, A., Noël, H., & Van Ypersele de Strihou, C. (1998). Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. Kidney International, 54(3), 956-959. https://doi.org/10.1046/j.1523-1755.1998.00064.x (Original work published 1998)